Results 351 to 360 of about 127,437 (365)

New Promise and Opportunities for Allosteric Kinase Inhibitors

Angewandte Chemie - International Edition, 2020
Xiaoyun Lu, Jeff B Smaill, Ke Ding
exaly  

Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target

Nature Reviews Drug Discovery, 2020
Lauren Mifflin, Junying Yuan
exaly  

Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes

Nature Reviews Drug Discovery, 2011
Kyle L Kolaja
exaly  

Rho kinase, a promising drug target for neurological disorders

Nature Reviews Drug Discovery, 2005
Nicole Teusch
exaly  

Targeting innate immunity protein kinase signalling in inflammation

Nature Reviews Drug Discovery, 2009
Matthias Gaestel, Michael Kracht
exaly  

INVESTIGATION OF CALMODULIN‐REGULATED NAD KINASE IN PROLIFERATING FIBROBLASTS*

Annals of the New York Academy of Sciences, 1980
Martina L. Veigl, Thomas C. Vanaman
openaire   +3 more sources

Factors underlying sensitivity of cancers to small-molecule kinase inhibitors

Nature Reviews Drug Discovery, 2009
Pasi A Jänne
exaly  

Non-kinase targets of protein kinase inhibitors

Nature Reviews Drug Discovery, 2017
Lenka Munoz
exaly  

Understanding, recognizing, and managing toxicities of targeted anticancer therapies

Ca-A Cancer Journal for Clinicians, 2013
exaly  

FDA-approved small-molecule kinase inhibitors

Trends in Pharmacological Sciences, 2015
Peng Wu, Mads H Clausen
exaly